vs
Side-by-side financial comparison of GERON CORP (GERN) and Voyager Technologies, Inc. (VOYG). Click either name above to swap in a different company.
GERON CORP is the larger business by last-quarter revenue ($47.2M vs $35.2M, roughly 1.3× Voyager Technologies, Inc.). GERON CORP runs the higher net margin — -39.0% vs -130.4%, a 91.3% gap on every dollar of revenue. On growth, GERON CORP posted the faster year-over-year revenue change (67.1% vs 2.1%).
Geron Corporation is a biotechnology company located in Foster City, California which specializes in developing and commercializing therapeutic products for cancer that inhibit telomerase.
GERN vs VOYG — Head-to-Head
Income Statement — Q3 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $47.2M | $35.2M |
| Net Profit | $-18.4M | $-45.9M |
| Gross Margin | — | -4.4% |
| Operating Margin | -29.4% | — |
| Net Margin | -39.0% | -130.4% |
| Revenue YoY | 67.1% | 2.1% |
| Net Profit YoY | 30.3% | -64.5% |
| EPS (diluted) | $-0.03 | $-0.75 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $35.2M | ||
| Q4 25 | — | $46.7M | ||
| Q3 25 | $47.2M | $39.6M | ||
| Q2 25 | $49.0M | $45.7M | ||
| Q1 25 | $39.6M | — | ||
| Q3 24 | $28.3M | — | ||
| Q2 24 | $882.0K | — | ||
| Q1 24 | $304.0K | — |
| Q1 26 | — | $-45.9M | ||
| Q4 25 | — | $-33.0M | ||
| Q3 25 | $-18.4M | $-16.3M | ||
| Q2 25 | $-16.4M | $-31.4M | ||
| Q1 25 | $-19.8M | — | ||
| Q3 24 | $-26.4M | — | ||
| Q2 24 | $-67.4M | — | ||
| Q1 24 | $-55.4M | — |
| Q1 26 | — | -4.4% | ||
| Q4 25 | — | 21.4% | ||
| Q3 25 | — | 15.4% | ||
| Q2 25 | — | 18.0% | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | -29.4% | -60.7% | ||
| Q2 25 | -25.4% | -52.8% | ||
| Q1 25 | -42.2% | — | ||
| Q3 24 | -99.8% | — | ||
| Q2 24 | -7860.9% | — | ||
| Q1 24 | -18465.1% | — |
| Q1 26 | — | -130.4% | ||
| Q4 25 | — | -70.7% | ||
| Q3 25 | -39.0% | -41.1% | ||
| Q2 25 | -33.4% | -68.7% | ||
| Q1 25 | -50.1% | — | ||
| Q3 24 | -93.5% | — | ||
| Q2 24 | -7639.8% | — | ||
| Q1 24 | -18220.4% | — |
| Q1 26 | — | $-0.75 | ||
| Q4 25 | — | $-0.52 | ||
| Q3 25 | $-0.03 | $-0.28 | ||
| Q2 25 | $-0.02 | $-1.23 | ||
| Q1 25 | $-0.03 | — | ||
| Q3 24 | $-0.04 | — | ||
| Q2 24 | $-0.10 | — | ||
| Q1 24 | $-0.09 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $78.1M | $429.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $248.7M | $404.5M |
| Total Assets | $567.4M | $1.0B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $429.4M | ||
| Q4 25 | — | $491.3M | ||
| Q3 25 | $78.1M | $413.3M | ||
| Q2 25 | $77.7M | $468.9M | ||
| Q1 25 | $83.7M | — | ||
| Q3 24 | $60.3M | — | ||
| Q2 24 | $116.9M | — | ||
| Q1 24 | $189.8M | — |
| Q1 26 | — | $404.5M | ||
| Q4 25 | — | — | ||
| Q3 25 | $248.7M | $590.9M | ||
| Q2 25 | $259.5M | $554.7M | ||
| Q1 25 | $268.2M | — | ||
| Q3 24 | $292.3M | — | ||
| Q2 24 | $306.7M | — | ||
| Q1 24 | $344.9M | — |
| Q1 26 | — | $1.0B | ||
| Q4 25 | — | — | ||
| Q3 25 | $567.4M | $727.8M | ||
| Q2 25 | $555.2M | $685.3M | ||
| Q1 25 | $562.5M | — | ||
| Q3 24 | $444.9M | — | ||
| Q2 24 | $449.4M | — | ||
| Q1 24 | $482.1M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-13.6M | $-39.7M |
| Free Cash FlowOCF − Capex | — | $-66.8M |
| FCF MarginFCF / Revenue | — | -189.5% |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-263.9M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $-39.7M | ||
| Q4 25 | — | $-60.9M | ||
| Q3 25 | $-13.6M | $-15.1M | ||
| Q2 25 | $-27.4M | $-30.9M | ||
| Q1 25 | $-48.0M | — | ||
| Q3 24 | $-58.9M | — | ||
| Q2 24 | $-53.5M | — | ||
| Q1 24 | $-62.3M | — |
| Q1 26 | — | $-66.8M | ||
| Q4 25 | — | $-54.5M | ||
| Q3 25 | — | $-53.8M | ||
| Q2 25 | — | $-88.8M | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $-53.7M | — | ||
| Q1 24 | $-62.9M | — |
| Q1 26 | — | -189.5% | ||
| Q4 25 | — | -116.9% | ||
| Q3 25 | — | -135.8% | ||
| Q2 25 | — | -194.4% | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -6086.6% | — | ||
| Q1 24 | -20680.3% | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 97.8% | ||
| Q2 25 | — | 126.7% | ||
| Q1 25 | — | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 23.4% | — | ||
| Q1 24 | 202.3% | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
